Tag: mRNA manufacturing capability
Monash awarded $5m grant to manufacture Australia’s first COVID-19 vaccine candidate
The Monash Institute of Pharmaceutical Sciences (MIPS) has received $5 million from the Victorian Government to manufacture doses of Australia’s first COVID-19 vaccine candidate...
Victoria to establish commercial-scale mRNA manufacturing capability within a year
The Victorian Government has announced the establishment of mRNA Victoria, a new dedicated organisation charged with building the state’s mRNA manufacturing capability.
mRNA Victoria, to...
Featured Article
What spending reveals about downstream consumer demand for manufactured goods
For manufacturers supplying consumer-facing markets, understanding demand conditions has become increasingly important in an environment shaped by cautious spending, rising costs and intense competition.
